Enhancer hijacking emerges as a major “missing driver” mechanism in LBCL/PCN, enabling detection of non-chimeric oncogene activation such as IGL::BCL2, IGH::CCND2, and MAFA/MAFB rearrangements.

"Population-scale spatial has arrived and is on center-stage at AGBT 2026," stated Christopher Mason, PhD, Professor of Physiology and Biophysics at Weill Cornell Medicine. " [Jiwoon Park] is ...

Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer ...

WOBURN, Mass.--(BUSINESS WIRE)--Covaris, LLC, a leader in pre-analytical sample preparation technologies, proudly unveils a comprehensive, fully automatable deparaffinization and total nucleic acid ...

Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial A single-center, nonrandomized ...

Both processing methods—formalin-fixed paraffin-embedded (FFPE) and flash-frozen—effectively preserve biospecimens. However, the choice between them depends upon the specific application. BioIVT, ...